Pharmalot... Pharmalittle... Good Morning

Welcome to the working week. Once again, another weekend respite has come and gone very quickly. Nonetheless, we hope you found it refreshing, if not invigorating, because that familiar routine of meetings and deadlines and varied pressures has now returned. To cope - yes - we are downing a cup or three of needed stimulation and, as always, invite you to join us. Firing up those neurons is a necessary and welcome step right now. Meanwhile, here are some tidbits. Hope your day goes well and do stay in touch... AstraZeneca Buys Pearl Therapeutics For $1.1B For COPD Drug (Pharma Times) Elan Board Rejects $6.7B Offer From Royalty Pharma (Bloomberg News) EU Approves Roche Drug To Treat Arthritis In Children (Reuters) Shire CEO Tries To Dampen Talk About Takeover Bait (Bloomberg News) Valent Backs Out Of Bid For Serbia's Galenika Pharmaceuticals (Reuters) Indian Regulator To Inspect Two Ranbaxy Plants (Economic Times) France Probes Death Involving Incorrectly Packaged Teva Pills (Reuters) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs